<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
59353-065-12
</NDCCode>
<PackageDescription>
12 VIAL, SINGLE-USE in 1 TRAY (59353-065-12) / 1.3 mL in 1 VIAL, SINGLE-USE (59353-065-01)
</PackageDescription>
<NDC11Code>
59353-0065-12
</NDC11Code>
<ProductNDC>
59353-065
</ProductNDC>
<ProductTypeName>
HUMAN PRESCRIPTION DRUG
</ProductTypeName>
<ProprietaryName>
Korsuva
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Difelikefalin
</NonProprietaryName>
<DosageFormName>
INJECTION, SOLUTION
</DosageFormName>
<RouteName>
INTRAVENOUS
</RouteName>
<StartMarketingDate>
20211101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
NDA
</MarketingCategoryName>
<ApplicationNumber>
NDA214916
</ApplicationNumber>
<LabelerName>
Vifor (International), Inc.
</LabelerName>
<SubstanceName>
DIFELIKEFALIN ACETATE
</SubstanceName>
<StrengthNumber>
50
</StrengthNumber>
<StrengthUnit>
ug/mL
</StrengthUnit>
<Pharm_Classes>
Kappa Opioid Receptor Agonist [EPC], Opioid kappa Receptor Agonists [MoA]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2025-09-02
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20261231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20211101
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>